The Robert Koch Institute has dampened hopes for a speedy vaccine against the Coronavirus. “Personally, I think it is realistic that it will be in the spring of 2021,” said President Lothar Wieler.
Everything was bureaucratically feasible, needs to be done. Clinical test phases, but you could not shorten. “We need to have a profile of a security. Vaccines can have side effects.”
Previously, Dietmar Hopp, co-owner of the tübingen-based pharmaceutical company had said CureVac, to be able to may already be in the autumn, a vaccine against Sars-CoV-2 deliver.
CureVac is one of many companies and research institutions currently working in the world of possible vaccines.
Also Federal Minister of research, Anja Karliczek (CDU) calls for patience. “Everywhere the researchers are working researchers with high-pressure. We are with you in a tight exchange, but the development takes time,” she said the ‘Passauer Neue Presse’.
There is in the development of drugs with high safety standards. “As far as we can answer, we try to accelerate the process.”
Search for Corona vaccine is in full swing
In the search for an effective against the disease Covid-19 protective vaccine researchers to rely on biotechnological processes.
This is not needed as it is usually the Virus itself for the manufacture of a vaccine, but only his genetic Information. That should at least shorten the time that it takes to be a vaccine candidate for testing in clinical trials to provide.
In the genetic Information of everything the Virus needs to manufacture its individual components and thus for its own reproduction – is.
This also includes those components, to which the body reacts to a vaccination, with the formation of antibodies and other defensive substances.
Photo gallery: 10 tips to protect yourself against viruses and bacteria
Admission procedure need time
The development of a vaccine candidate, however, is only the first step. Very tedious it is then: The admission and clinical examination of the candidates are in the development phase, the Lingen on most of the time.
After Trying in cells and in an animal model, as well as the Toxicological testing the safety of a vaccine is tested-candidate first to a few people. Then larger clinical trials will follow.
In the United States has already got a Volunteer to test a possible vaccine against the novel Coronavirus injected, as reported to the U.S. Department of health belonging to the National Institutes of Health (NIH) on Monday.
A total of 45 healthy participants between 18 and 55 years of age to participate in the coming weeks at the security test.
The vaccine called “mRNA-1273” is developed together with the private biotechnology company Moderna. The first test phase could be started in “record time,” said Anthony Fauci, Director of the National Institute for infectious diseases.
The entire process of development but is expected to take at least one to one and a half years.
Deutsche Presse-Agentur (dpa)
*The post “Against Sars-CoV-2: Corona vaccine is according to the RKI in the spring of 2021 realistic,” published by FitForFun. Contact with the executives here.